Emergent BioSolutions Quarterly Balance Sheets Chart
Quarterly
|
Annual
Emergent BioSolutions Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2016-03-31 | 2015-12-31 | 2013-12-31 | 2013-09-30 | 2013-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2003-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||||||||||||||||||||||||
| current assets: | |||||||||||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 111,700,000 | 87,800,000 | 88,600,000 | 430,200,000 | 642,600,000 | 240,900,000 | 358,100,000 | 435,800,000 | 576,100,000 | 403,800,000 | 447,500,000 | 547,800,000 | 621,300,000 | 415,000,000 | 268,800,000 | 181,500,000 | 167,800,000 | 139,200,000 | 177,400,000 | 137,200,000 | 112,200,000 | 178,292,000 | 271,513,000 | 341,016,000 | 312,795,000 | 179,338,000 | 172,561,000 | 130,238,000 | 143,901,000 | 125,346,000 | 122,094,000 | 136,925,000 | 169,019,000 | 151,229,000 | 102,193,000 | 116,384,000 | 102,924,000 | 118,777,000 | 102,508,000 | 61,380,000 | 91,473,000 | 104,688,000 | 84,007,000 | 92,747,000 | 105,730,000 | 24,266,000 | 33,980,000 | 67,645,000 | 7,119,000 |
| accounts receivable | 191,000,000 | 216,500,000 | 290,100,000 | 155,900,000 | 158,400,000 | 191,300,000 | 175,000,000 | 181,800,000 | 274,700,000 | 254,600,000 | 261,900,000 | 184,400,000 | 230,900,000 | 196,100,000 | 258,600,000 | 162,500,000 | 270,700,000 | 281,200,000 | 218,100,000 | 121,500,000 | 262,500,000 | 143,653,000 | 138,478,000 | 69,560,000 | 120,767,000 | 60,587,000 | 30,093,000 | 62,964,000 | 74,153,000 | 48,994,000 | 47,263,000 | 11,976,000 | 39,326,000 | 7,937,000 | 45,765,000 | 33,405,000 | 54,872,000 | 25,713,000 | 55,399,000 | 74,136,000 | 24,855,000 | 14,070,000 | 22,451,000 | 21,518,000 | 18,817,000 | 42,013,000 | 19,397,000 | 3,935,000 | |
| inventories | 328,900,000 | 354,100,000 | 354,300,000 | 367,900,000 | 351,800,000 | 546,300,000 | 425,500,000 | 400,700,000 | 350,800,000 | 364,600,000 | 386,400,000 | 406,500,000 | 307,000,000 | 270,100,000 | 236,200,000 | 248,100,000 | 222,500,000 | 230,200,000 | 232,000,000 | 211,000,000 | 205,800,000 | 142,812,000 | 74,002,000 | 88,200,000 | 76,936,000 | 14,643,000 | 16,325,000 | 22,148,000 | 14,661,000 | 17,979,000 | 17,262,000 | 22,163,000 | 12,722,000 | 17,320,000 | 17,116,000 | 17,081,000 | 13,521,000 | 15,816,000 | 14,042,000 | 14,152,000 | 19,728,000 | 17,516,000 | 18,879,000 | 18,790,000 | 16,897,000 | 25,623,000 | 28,885,000 | 26,885,000 | |
| prepaid expenses and other current assets | 47,900,000 | 62,400,000 | 44,700,000 | 41,700,000 | 57,900,000 | 139,900,000 | 125,400,000 | 81,800,000 | 70,300,000 | 88,300,000 | 66,100,000 | 42,200,000 | 36,500,000 | 77,400,000 | 32,100,000 | 24,100,000 | 20,400,000 | 49,200,000 | 65,000,000 | 58,600,000 | 31,500,000 | 17,157,000 | 16,229,000 | 25,613,000 | 21,541,000 | 12,896,000 | 13,184,000 | 9,703,000 | 8,276,000 | 9,033,000 | 7,742,000 | 7,875,000 | 8,814,000 | 8,690,000 | 7,732,000 | 7,271,000 | 7,838,000 | 6,131,000 | 4,303,000 | 4,253,000 | 6,623,000 | 5,700,000 | 4,691,000 | 3,074,000 | 2,866,000 | 2,475,000 | 2,561,000 | 1,970,000 | |
| total current assets | 679,500,000 | 720,800,000 | 777,700,000 | 1,221,300,000 | 1,210,700,000 | 1,118,500,000 | 1,084,200,000 | 1,100,300,000 | 1,272,100,000 | 1,111,500,000 | 1,162,100,000 | 1,181,100,000 | 1,195,900,000 | 958,800,000 | 795,900,000 | 626,600,000 | 686,200,000 | 700,000,000 | 692,700,000 | 528,500,000 | 620,800,000 | 485,389,000 | 510,218,000 | 528,160,000 | 538,612,000 | 273,115,000 | 234,015,000 | 237,079,000 | 254,418,000 | 236,765,000 | 223,844,000 | 216,203,000 | 243,493,000 | 210,836,000 | 194,446,000 | 191,536,000 | 193,814,000 | 195,417,000 | 203,722,000 | 163,921,000 | 152,679,000 | 151,974,000 | 140,028,000 | 139,629,000 | 144,310,000 | 107,363,000 | 99,610,000 | 103,690,000 | |
| property, plant and equipment | 382,800,000 | 395,400,000 | 395,500,000 | 716,800,000 | 817,600,000 | 806,700,000 | 798,400,000 | 807,500,000 | 800,100,000 | 768,700,000 | 743,500,000 | 692,900,000 | 644,100,000 | 606,500,000 | 580,100,000 | 549,200,000 | 542,300,000 | 529,100,000 | 520,500,000 | 513,400,000 | 510,200,000 | 407,210,000 | 376,448,000 | 342,083,000 | 331,856,000 | 264,240,000 | 263,056,000 | 242,344,000 | 208,973,000 | 188,245,000 | 172,481,000 | 157,963,000 | 152,701,000 | 141,257,000 | 136,839,000 | 133,493,000 | 131,834,000 | 112,645,000 | 110,383,000 | 127,245,000 | 124,656,000 | 120,898,000 | 118,365,000 | 115,421,000 | 110,218,000 | 103,479,000 | 96,576,000 | 87,836,000 | |
| intangible assets | 566,600,000 | 582,800,000 | 592,800,000 | 608,900,000 | 728,800,000 | 722,700,000 | 576,600,000 | 590,600,000 | 604,600,000 | 618,600,000 | 633,100,000 | 648,200,000 | 663,100,000 | 678,100,000 | 693,200,000 | 708,100,000 | 712,900,000 | 727,700,000 | 742,400,000 | 757,100,000 | 761,600,000 | 119,597,000 | 33,865,000 | 55,010,000 | 57,375,000 | 30,148,000 | 30,771,000 | ||||||||||||||||||||||
| goodwill | 218,200,000 | 218,200,000 | 218,200,000 | 224,900,000 | 224,900,000 | 224,900,000 | 224,900,000 | 266,500,000 | 266,600,000 | 266,500,000 | 266,700,000 | 266,500,000 | 266,300,000 | 266,400,000 | 266,600,000 | 268,600,000 | 268,300,000 | 267,700,000 | 259,700,000 | 49,130,000 | 41,001,000 | 54,902,000 | 54,902,000 | 13,954,000 | 14,294,000 | 5,502,000 | 5,502,000 | 5,502,000 | 5,029,000 | 5,029,000 | 5,029,000 | ||||||||||||||||||
| other assets | 194,300,000 | 194,100,000 | 194,600,000 | 184,600,000 | 191,300,000 | 35,700,000 | 51,300,000 | 57,100,000 | 57,300,000 | 102,200,000 | 109,900,000 | 111,400,000 | 113,400,000 | 106,400,000 | 101,600,000 | 81,800,000 | 76,900,000 | 67,400,000 | 56,400,000 | 46,000,000 | 13,700,000 | 6,046,000 | 2,483,000 | 2,117,000 | 7,060,000 | 3,373,000 | 441,000 | 573,000 | 807,000 | 707,000 | 712,000 | 1,129,000 | 1,198,000 | 1,128,000 | 1,133,000 | 1,177,000 | 1,187,000 | 1,451,000 | 1,121,000 | 1,163,000 | 1,172,000 | 1,726,000 | 1,364,000 | 1,580,000 | 1,383,000 | 1,412,000 | 1,432,000 | 1,293,000 | |
| total assets | 1,823,200,000 | 1,893,100,000 | 2,178,800,000 | 2,949,800,000 | 3,166,600,000 | 2,908,500,000 | 2,735,400,000 | 2,780,400,000 | 2,959,000,000 | 2,867,500,000 | 2,915,200,000 | 2,900,100,000 | 2,883,200,000 | 2,616,300,000 | 2,466,100,000 | 2,278,700,000 | 2,327,300,000 | 2,333,800,000 | 2,321,300,000 | 2,153,700,000 | 2,229,400,000 | 1,070,206,000 | 970,111,000 | 1,035,897,000 | 1,043,592,000 | 626,630,000 | 595,464,000 | 538,385,000 | 546,864,000 | 512,962,000 | 493,984,000 | 471,277,000 | 500,319,000 | 366,237,000 | 345,747,000 | 342,791,000 | 344,689,000 | 316,802,000 | 326,385,000 | 303,782,000 | 290,788,000 | 287,396,000 | 277,919,000 | 273,641,000 | 273,508,000 | 226,751,000 | 206,996,000 | 203,893,000 | 37,127,000 |
| liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable | 112,200,000 | 112,700,000 | 108,300,000 | 124,200,000 | 103,500,000 | 103,800,000 | 106,200,000 | 107,300,000 | 128,900,000 | 135,200,000 | 151,800,000 | 142,200,000 | 136,100,000 | 102,800,000 | 84,800,000 | 84,200,000 | 94,800,000 | 91,300,000 | 124,500,000 | 78,600,000 | 80,700,000 | 41,751,000 | 34,649,000 | 45,611,000 | 45,966,000 | 27,521,000 | 29,018,000 | 23,871,000 | 40,530,000 | 33,902,000 | 32,182,000 | 24,034,000 | 25,409,000 | 22,518,000 | 20,300,000 | 16,164,000 | 17,159,000 | 21,236,000 | 17,568,000 | 17,186,000 | 18,254,000 | 16,673,000 | 19,933,000 | 17,863,000 | 17,979,000 | 19,383,000 | 17,347,000 | 19,003,000 | |
| accrued expenses | 18,600,000 | 17,000,000 | 31,200,000 | 21,300,000 | 34,900,000 | 35,900,000 | 40,300,000 | 29,300,000 | 51,700,000 | 42,900,000 | 33,800,000 | 25,000,000 | 46,900,000 | 34,900,000 | 33,800,000 | 41,500,000 | 39,500,000 | 51,800,000 | 54,800,000 | 49,600,000 | |||||||||||||||||||||||||||||
| accrued compensation | 74,100,000 | 82,500,000 | 69,600,000 | 56,800,000 | 88,300,000 | 82,500,000 | 74,400,000 | 56,400,000 | 88,700,000 | 73,400,000 | 63,200,000 | 55,000,000 | 84,600,000 | 76,900,000 | 59,000,000 | 47,500,000 | 62,400,000 | 55,800,000 | 44,700,000 | 36,900,000 | 58,200,000 | 37,882,000 | 34,537,000 | 26,528,000 | 34,683,000 | 24,615,000 | 18,421,000 | 11,675,000 | 20,884,000 | 14,735,000 | 13,823,000 | 13,687,000 | 23,975,000 | 13,749,000 | 11,580,000 | 9,346,000 | 14,926,000 | 14,163,000 | 9,962,000 | 8,286,000 | 11,380,000 | 10,378,000 | 7,315,000 | 6,592,000 | 9,502,000 | 7,616,000 | 7,609,000 | 4,723,000 | |
| debt, current portion | 413,700,000 | 413,600,000 | 455,200,000 | 950,700,000 | 957,300,000 | 21,200,000 | 31,600,000 | 31,600,000 | 31,600,000 | 31,600,000 | 28,800,000 | 26,000,000 | 33,800,000 | 30,900,000 | 29,100,000 | 26,300,000 | 12,900,000 | 10,100,000 | 10,100,000 | ||||||||||||||||||||||||||||||
| other current liabilities | 32,700,000 | 38,200,000 | 28,900,000 | 25,200,000 | 45,900,000 | 25,000,000 | 24,200,000 | 24,600,000 | 72,900,000 | 82,300,000 | 100,200,000 | 122,000,000 | 83,100,000 | 53,800,000 | 32,000,000 | 7,600,000 | 3,500,000 | 10,600,000 | 12,500,000 | 10,500,000 | |||||||||||||||||||||||||||||
| total current liabilities | 651,300,000 | 664,000,000 | 693,200,000 | 1,215,700,000 | 1,229,900,000 | 268,400,000 | 276,700,000 | 249,200,000 | 373,800,000 | 365,400,000 | 377,800,000 | 370,200,000 | 384,500,000 | 299,300,000 | 293,700,000 | 207,100,000 | 216,300,000 | 275,300,000 | 301,200,000 | 248,400,000 | 200,400,000 | 100,068,000 | 105,856,000 | 90,455,000 | 99,611,000 | 56,651,000 | 56,632,000 | 43,541,000 | 71,054,000 | 68,931,000 | 72,504,000 | 70,934,000 | 75,719,000 | 49,858,000 | 45,444,000 | 48,123,000 | 54,701,000 | 57,307,000 | 72,910,000 | 54,206,000 | 54,021,000 | 51,568,000 | 52,370,000 | 49,381,000 | 55,661,000 | 35,511,000 | 32,261,000 | 30,465,000 | |
| debt, net of current portion | 446,500,000 | 448,200,000 | 448,000,000 | 447,700,000 | 448,500,000 | 1,032,100,000 | 793,600,000 | 801,500,000 | 809,400,000 | 817,300,000 | 825,200,000 | 833,100,000 | 841,000,000 | 848,500,000 | 758,100,000 | 762,900,000 | 798,400,000 | ||||||||||||||||||||||||||||||||
| deferred tax liability | 47,200,000 | 52,400,000 | 57,900,000 | 59,700,000 | 71,800,000 | 113,800,000 | 93,400,000 | 94,800,000 | 94,900,000 | 53,000,000 | 53,200,000 | 53,300,000 | 53,200,000 | 64,000,000 | 63,900,000 | 63,900,000 | 63,900,000 | 61,100,000 | 65,600,000 | 66,400,000 | 67,500,000 | 88,000 | 243,000 | 195,000 | 104,000 | ||||||||||||||||||||||||
| other liabilities | 28,900,000 | 31,300,000 | 23,400,000 | 24,100,000 | 33,400,000 | 44,900,000 | 58,500,000 | 49,300,000 | 52,700,000 | 58,700,000 | 61,400,000 | 62,900,000 | 67,800,000 | 57,400,000 | 59,400,000 | 58,900,000 | 48,600,000 | 53,000,000 | 47,800,000 | 44,300,000 | 38,000,000 | 4,675,000 | 1,604,000 | 1,337,000 | 1,328,000 | 2,117,000 | 1,768,000 | 1,852,000 | 1,984,000 | 1,882,000 | 2,017,000 | 1,940,000 | 1,882,000 | 1,160,000 | 1,350,000 | 1,387,000 | 1,246,000 | 1,613,000 | 1,823,000 | 1,587,000 | 1,483,000 | 1,495,000 | 1,649,000 | 1,636,000 | 1,627,000 | 1,574,000 | 1,922,000 | 1,802,000 | |
| total liabilities | 1,173,900,000 | 1,195,900,000 | 1,222,500,000 | 1,747,200,000 | 1,783,600,000 | 1,459,200,000 | 1,222,200,000 | 1,205,100,000 | 1,340,000,000 | 1,344,800,000 | 1,371,500,000 | 1,377,300,000 | 1,436,200,000 | 1,364,800,000 | 1,267,300,000 | 1,203,900,000 | 1,238,800,000 | 1,298,800,000 | 1,332,400,000 | 1,166,200,000 | 1,218,500,000 | 157,861,000 | 373,906,000 | 368,915,000 | 383,575,000 | 137,465,000 | 128,607,000 | 102,580,000 | 130,137,000 | 128,459,000 | 112,754,000 | 112,354,000 | 126,758,000 | 87,243,000 | 83,704,000 | 93,675,000 | 100,874,000 | 79,420,000 | 95,983,000 | 91,001,000 | 91,439,000 | 94,567,000 | 96,804,000 | 95,044,000 | 102,349,000 | 83,258,000 | 66,976,000 | 65,872,000 | |
| stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15.0 shares authorized, no shares issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||
| common stock | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 50,000 | 41,000 | 40,000 | 40,000 | 37,000 | 37,000 | 36,000 | 36,000 | 36,000 | 36,000 | 35,000 | 35,000 | 31,000 | 31,000 | 31,000 | 31,000 | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 | 28,000 | ||||
| treasury stock | -227,700,000 | -227,700,000 | -227,700,000 | -227,700,000 | -227,700,000 | -227,700,000 | -227,700,000 | -204,400,000 | -152,200,000 | -39,600,000 | -39,600,000 | -39,600,000 | -39,600,000 | -39,600,000 | -39,600,000 | -39,600,000 | -39,600,000 | -39,700,000 | -39,700,000 | -39,600,000 | -39,600,000 | -39,497,000 | -6,420,000 | -6,420,000 | -6,420,000 | -6,119,000 | -5,906,000 | -5,906,000 | |||||||||||||||||||||
| additional paid-in capital | 904,400,000 | 899,700,000 | 895,800,000 | 878,200,000 | 873,500,000 | 860,100,000 | 849,200,000 | 834,800,000 | 829,400,000 | 816,800,000 | 804,400,000 | 790,100,000 | 784,900,000 | 770,900,000 | 758,500,000 | 726,200,000 | 716,100,000 | 708,800,000 | 701,800,000 | 690,200,000 | 688,600,000 | 618,416,000 | 352,435,000 | 322,384,000 | 317,971,000 | 247,637,000 | 240,372,000 | 232,887,000 | 220,654,000 | 215,938,000 | 213,320,000 | 204,367,000 | 197,689,000 | 130,832,000 | 127,349,000 | 123,643,000 | 120,492,000 | 118,563,000 | 113,066,000 | 110,877,000 | 109,170,000 | 104,288,000 | 103,134,000 | 102,163,000 | 101,933,000 | 101,992,000 | 101,203,000 | 93,936,000 | |
| accumulated other comprehensive income | -5,700,000 | -2,600,000 | -1,600,000 | 1,000,000 | 3,100,000 | ||||||||||||||||||||||||||||||||||||||||||||
| retained earnings | -21,800,000 | 27,700,000 | 289,700,000 | 551,000,000 | 734,000,000 | 822,000,000 | 897,700,000 | 954,100,000 | 957,800,000 | 768,500,000 | 801,200,000 | 796,600,000 | 726,900,000 | 541,500,000 | 502,000,000 | 409,300,000 | 421,800,000 | 374,900,000 | 331,700,000 | 341,300,000 | 367,300,000 | 337,074,000 | 254,480,000 | 355,130,000 | 351,139,000 | 251,528,000 | 236,305,000 | 212,330,000 | 196,869,000 | 168,212,000 | 166,663,000 | 152,453,000 | 173,850,000 | 147,602,000 | 134,482,000 | 124,675,000 | 122,152,000 | 117,918,000 | 116,970,000 | 102,127,000 | 91,008,000 | 89,551,000 | 79,166,000 | 77,350,000 | 70,326,000 | 42,588,000 | 39,741,000 | 44,700,000 | |
| total stockholders’ equity | 649,300,000 | 697,200,000 | 956,300,000 | 1,202,600,000 | 1,383,000,000 | 1,619,000,000 | 1,447,000,000 | 1,088,500,000 | 1,010,900,000 | 416,727,000 | 384,503,000 | 381,230,000 | 358,923,000 | 373,561,000 | 278,994,000 | 262,043,000 | 249,116,000 | 243,815,000 | 237,382,000 | 230,402,000 | 212,781,000 | 199,349,000 | 192,829,000 | 181,115,000 | 178,597,000 | 171,159,000 | 143,493,000 | 140,020,000 | 138,021,000 | 8,448,000 | |||||||||||||||||||
| total liabilities and stockholders’ equity | 1,823,200,000 | 1,893,100,000 | 2,178,800,000 | 2,949,800,000 | 3,166,600,000 | 2,959,000,000 | 2,883,200,000 | 2,327,300,000 | 2,229,400,000 | 546,864,000 | 512,962,000 | 493,984,000 | 471,277,000 | 500,319,000 | 366,237,000 | 345,747,000 | 342,791,000 | 344,689,000 | 316,802,000 | 326,385,000 | 303,782,000 | 290,788,000 | 287,396,000 | 277,919,000 | 273,641,000 | 273,508,000 | 226,751,000 | 206,996,000 | 203,893,000 | ||||||||||||||||||||
| liabilities and stockholders' equity | |||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders' equity: | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share; 15.0 shares authorized, no shares issued or outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||
| assets held for sale | 225,600,000 | 11,765,000 | 12,065,000 | 12,548,000 | 12,741,000 | 12,741,000 | 12,930,000 | 12,930,000 | 13,411,000 | 13,960,000 | 17,470,000 | 17,470,000 | |||||||||||||||||||||||||||||||||||||
| liabilities held for sale | 37,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15.0 shares authorized, no shares issued or outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||
| restricted cash | 100,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 1,043,000 | 220,000 | 217,000 | 217,000 | 217,000 | 217,000 | 215,000 | 215,000 | 215,000 | 215,000 | 208,000 | 208,000 | 208,000 | 208,000 | 200,000 | 5,200,000 | 5,200,000 | 5,200,000 | 5,192,000 | ||||||||||||||
| accumulated other comprehensive loss | -5,200,000 | -6,100,000 | -9,300,000 | -16,100,000 | -23,100,000 | -22,400,000 | -24,400,000 | -25,300,000 | -21,400,000 | -22,200,000 | -21,200,000 | -9,900,000 | -9,100,000 | -5,000,000 | -4,500,000 | -5,500,000 | -3,698,000 | -4,331,000 | -4,152,000 | -2,713,000 | -3,465,000 | -3,502,000 | -3,759,000 | -3,313,000 | -2,894,000 | -2,771,000 | -2,803,000 | -2,110,000 | -2,173,000 | -1,641,000 | -1,261,000 | -1,476,000 | -1,130,000 | -1,214,000 | -939,000 | -859,000 | -1,040,000 | -1,215,000 | -946,000 | -1,130,000 | -1,117,000 | -954,000 | -643,000 | ||||||
| total stockholders' equity | 1,449,300,000 | 1,513,200,000 | 1,575,300,000 | 1,522,700,000 | 1,543,700,000 | 1,522,800,000 | 1,251,500,000 | 1,198,800,000 | 1,074,800,000 | 1,035,000,000 | 988,900,000 | 987,500,000 | 912,345,000 | 596,205,000 | 666,982,000 | 660,017,000 | 489,165,000 | 466,857,000 | 435,805,000 | ||||||||||||||||||||||||||||||
| total liabilities and stockholders' equity | 2,908,500,000 | 2,735,400,000 | 2,780,400,000 | 2,867,500,000 | 2,915,200,000 | 2,900,100,000 | 2,616,300,000 | 2,466,100,000 | 2,278,700,000 | 2,333,800,000 | 2,321,300,000 | 2,153,700,000 | 1,070,206,000 | 970,111,000 | 1,035,897,000 | 1,043,592,000 | 626,630,000 | 595,464,000 | 538,385,000 | ||||||||||||||||||||||||||||||
| contingent consideration, net of current portion | 4,400,000 | 4,500,000 | 5,100,000 | 5,000,000 | 5,300,000 | 34,200,000 | 35,200,000 | 6,900,000 | 26,100,000 | 26,000,000 | 54,400,000 | 9,902,000 | 9,919,000 | 23,114,000 | 23,046,000 | ||||||||||||||||||||||||||||||||||
| contract liabilities, net of current portion | 5,900,000 | 4,700,000 | 45,300,000 | 48,900,000 | 52,500,000 | 55,500,000 | 60,400,000 | 85,300,000 | 85,000,000 | 85,600,000 | |||||||||||||||||||||||||||||||||||||||
| in-process research and development | 29,000,000 | 29,000,000 | 29,000,000 | 41,000,000 | 41,000,000 | 41,000,000 | 50,000,000 | 42,501,000 | 42,501,000 | 41,800,000 | 41,800,000 | 41,800,000 | 51,400,000 | 51,400,000 | 51,400,000 | 51,400,000 | 51,400,000 | ||||||||||||||||||||||||||||||||
| contract liabilities, current portion | 32,700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| contingent consideration, current portion | 22,300,000 | 3,200,000 | 55,700,000 | 54,600,000 | 62,700,000 | 5,600,000 | 2,372,000 | 3,266,000 | 2,580,000 | 2,553,000 | |||||||||||||||||||||||||||||||||||||||
| income tax receivable | 10,200,000 | 4,600,000 | 8,600,000 | 2,432,000 | 9,996,000 | 3,771,000 | 6,573,000 | 5,651,000 | 588,000 | 10,762,000 | 9,506,000 | 24,488,000 | 17,136,000 | 23,966,000 | 8,728,000 | 13,206,000 | 8,788,000 | 5,033,000 | 2,574,000 | ||||||||||||||||||||||||||||||
| deferred tax assets | 17,600,000 | 13,400,000 | 13,400,000 | 2,834,000 | 6,096,000 | 11,124,000 | 1,264,000 | 1,264,000 | 1,735,000 | 7,209,000 | 7,082,000 | 6,743,000 | 2,638,000 | 2,239,000 | 2,637,000 | 2,147,000 | 1,870,000 | 7,081,000 | 10,951,000 | 11,245,000 | 12,073,000 | 12,598,000 | 12,962,000 | 11,811,000 | |||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15.0 shares authorized, 0 shares issued and outstanding at both december 31, 2019 and 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||
| contingent consideration | 14,500,000 | 10,400,000 | 10,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| debt | 813,300,000 | 830,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| contract liabilities | 81,600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| commitments and contingencies | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15.0 shares authorized, no shares issued or outstanding at both 2019 and 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue | 77,000,000 | 1,834,000 | 2,038,000 | 2,008,000 | 253,000 | 241,000 | 241,000 | 255,000 | 255,000 | 478,000 | |||||||||||||||||||||||||||||||||||||||
| long-term indebtedness, current portion | 10,100,000 | 10,100,000 | 4,470,000 | 4,470,000 | 5,360,000 | 4,920,000 | 10,229,000 | 16,927,000 | 17,187,000 | 12,038,000 | 12,186,000 | 5,797,000 | 5,791,000 | 19,087,000 | 19,308,000 | 6,316,000 | 6,248,000 | 3,739,000 | 3,707,000 | 3,524,000 | 3,514,000 | 3,485,000 | 2,597,000 | 2,638,000 | |||||||||||||||||||||||||
| long-term indebtedness | 732,400,000 | 13,457,000 | 248,094,000 | 247,192,000 | 253,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue, net of current portion | 64,700,000 | 62,500,000 | 17,259,000 | 8,433,000 | 6,817,000 | 6,590,000 | 2,781,000 | 2,953,000 | 3,823,000 | 4,386,000 | 1,853,000 | 2,180,000 | 2,325,000 | 2,473,000 | 2,685,000 | 2,773,000 | 2,859,000 | ||||||||||||||||||||||||||||||||
| accrued expenses and other current liabilities | 30,700,000 | 4,831,000 | 6,368,000 | 4,187,000 | 6,229,000 | 1,252,000 | 1,359,000 | 1,517,000 | 1,170,000 | 1,150,000 | 1,200,000 | 1,257,000 | 1,309,000 | 1,300,000 | 1,137,000 | 1,575,000 | 1,570,000 | 1,320,000 | 1,162,000 | 1,175,000 | 1,399,000 | 1,463,000 | 1,267,000 | 1,499,000 | 4,056,000 | 4,055,000 | 3,537,000 | 2,907,000 | |||||||||||||||||||||
| income taxes payable | 4,500,000 | 9,170,000 | 5,550,000 | 951,000 | 2,898,000 | 4,108,000 | 3,880,000 | 7,665,000 | |||||||||||||||||||||||||||||||||||||||||
| deferred revenue, current portion | 10,600,000 | 13,232,000 | 7,036,000 | 9,589,000 | 7,942,000 | 1,362,000 | 4,359,000 | 5,336,000 | 5,916,000 | 7,839,000 | 227,000 | 232,000 | 820,000 | 901,000 | 900,000 | 902,000 | 729,000 | 976,000 | 1,090,000 | ||||||||||||||||||||||||||||||
| long-term indebtedness, net of current portion | 784,500,000 | 62,000,000 | 54,952,000 | 57,187,000 | 54,094,000 | 48,873,000 | 29,074,000 | 29,657,000 | 30,239,000 | 36,225,000 | 36,910,000 | 44,165,000 | 44,927,000 | 20,500,000 | 21,250,000 | 35,208,000 | 35,935,000 | 39,651,000 | 40,605,000 | 41,702,000 | 42,588,000 | 43,488,000 | 30,020,000 | 30,746,000 | |||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15.0 shares authorized, 0 shares issued and outstanding at both december 31, 2018 and 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||
| notes payable | 20,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| income taxes payable, net of current | 12,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at both december 31, 2017 and december 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||
| current assets of discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
| non-current assets of discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities of discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
| non-current liabilities of discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at both december 31, 2016 and december 31, 2015 | |||||||||||||||||||||||||||||||||||||||||||||||||
| provisions for chargebacks | 1,960,000 | 2,238,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at both march 31, 2016 and december 31, 2015 | |||||||||||||||||||||||||||||||||||||||||||||||||
| deferred tax assets, current portion | |||||||||||||||||||||||||||||||||||||||||||||||||
| deferred tax assets, long-term portion | 11,286,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at both december 31, 2015 and december 31, 2014 | |||||||||||||||||||||||||||||||||||||||||||||||||
| contingent purchase consideration, current portion | 1,341,000 | 1,326,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| income tax payable | |||||||||||||||||||||||||||||||||||||||||||||||||
| contingent purchase consideration, net of current portion | 15,278,000 | 15,255,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at december 31, 2013 and december 31, 2012, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| total emergent biosolutions inc. stockholders' equity | 489,618,000 | 467,306,000 | 435,588,000 | 414,246,000 | 381,292,000 | 377,248,000 | 354,052,000 | 369,464,000 | 276,292,000 | 260,221,000 | 247,088,000 | 241,199,000 | 228,852,000 | 212,095,000 | |||||||||||||||||||||||||||||||||||
| noncontrolling interest in subsidiaries | -453,000 | -449,000 | 217,000 | 2,481,000 | 3,211,000 | 3,982,000 | 4,871,000 | ||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at september 30, 2013 and december 31, 2012, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at march 31, 2013 and december 31, 2012, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| investments | 1,966,000 | 3,499,000 | 5,048,000 | 6,338,000 | 2,029,000 | ||||||||||||||||||||||||||||||||||||||||||||
| contingent value rights, current portion | 1,748,000 | 9,865,000 | 9,734,000 | 9,113,000 | |||||||||||||||||||||||||||||||||||||||||||||
| contingent value rights, net of current portion | 3,005,000 | 5,992,000 | 6,206,000 | 6,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at december 31, 2011 and 2010, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at september 30, 2011 and december 31, 2010, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at june 30, 2011 and december 31, 2010, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at march 31, 2011 and december 31, 2010, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| note receivable | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | |||||||||||||||||||||||||||||||||||||||
| indebtedness under line of credit | 15,000,000 | 15,000,000 | 15,000,000 | 15,000,000 | 15,000,000 | 15,000,000 | 15,000,000 | ||||||||||||||||||||||||||||||||||||||||||
| contingent value rights | 14,532,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at december 31, 2010 and 2009, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| noncontrolling interest in subsidiary | 4,097,000 | 2,702,000 | 1,822,000 | 2,028,000 | 2,616,000 | 2,000,000 | 1,550,000 | 686,000 | |||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at september 30, 2010 and december 31, 2009, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at june 30, 2010 and december 31, 2009, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at march 31, 2010 and december 31, 2009, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| deferred tax liabilities | 1,246,000 | 262,000 | 466,000 | 557,000 | 597,000 | 139,000 | 123,000 | 211,000 | |||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, | |||||||||||||||||||||||||||||||||||||||||||||||||
| 0 shares issued and outstanding at december 31, 2009 and 2008, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| 30,831,360 and 30,159,546 shares issued and outstanding at | |||||||||||||||||||||||||||||||||||||||||||||||||
| december 31, 2009 and 2008, respectively | 31,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| income taxes receivable | 1,510,000 | 12,986,000 | 14,787,000 | 3,255,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at september 30, 2009 and december 31, 2008, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| total emergent biosolutions inc. stockholders’ equity | 235,382,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
| shares issued and outstanding at june 30, 2009 and december 31, 2008, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| 30,319,896 and 30,159,546 shares issued and outstanding at june 30, 2009 and december 31, 2008, respectively | 30,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| shares issued and outstanding at march 31, 2009 and december 31, 2008, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| 30,241,241 and 30,159,546 shares issued and outstanding at march 31, 2009 and december 31, 2008, respectively | 30,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at december 31, 2008 and 2007, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at september 30, 2008 and december 31, 2007 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at june 30, 2008 and december 31, 2007 | |||||||||||||||||||||||||||||||||||||||||||||||||
| notes receivable | 3,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| indebtedness under lines of credit | 15,000,000 | 11,832,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at march 31, 2008 and december 31, 2007. | |||||||||||||||||||||||||||||||||||||||||||||||||
| deferred tax assets, net of current | 12,397,000 | 9,305,000 | 9,378,000 | 11,074,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at december 31, 2007 and 2006, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at september 30, 2007 and december 31, 2006 | |||||||||||||||||||||||||||||||||||||||||||||||||
| notes payable to employees | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at june 30, 2007 and december 31, 2006 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock 0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at december 31, 2006 and march 31, 2007 | |||||||||||||||||||||||||||||||||||||||||||||||||
| balance sheet data: | |||||||||||||||||||||||||||||||||||||||||||||||||
| working capital | -3,147,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| total long-term liabilities | 1,228,000 |
We provide you with 20 years of balance sheets for Emergent BioSolutions stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Emergent BioSolutions. Explore the full financial landscape of Emergent BioSolutions stock with our expertly curated balance sheets.
The information provided in this report about Emergent BioSolutions stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.